Food, Drug & Cosmetic Law: Policy, Pricing, and Market Strategy

This program examines how recent developments in U.S. healthcare policy, including drug pricing reform, PBM regulation, and evolving regulatory frameworks, are influencing commercial strategy, valuation, and market behavior. The discussion focuses on how these policy shifts are beginning to shape real-world business decisions for healthcare and life sciences companies.

Speaker

Ron Lanton, Esq., Senior Partner, Lanton, Lanton & Sosa Law PLLC

President, Lanton Strategies International

Boston, MA / Washington, D.C./ Amsterdam